156 related articles for article (PubMed ID: 22205202)
1. Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo.
Fang L; Shanqu L; Ping G; Ting H; Xi W; Ke D; Min L; Junxia W; Huizhong Z
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1079-87. PubMed ID: 22205202
[TBL] [Abstract][Full Text] [Related]
2. Inhibition effect of siRNA-downregulated UHRF1 on breast cancer growth.
Yan F; Tan XY; Geng Y; Ju HX; Gao YF; Zhu MC
Cancer Biother Radiopharm; 2011 Apr; 26(2):183-9. PubMed ID: 21539450
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
4. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
6. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.
Long M; Yin G; Liu L; Lin F; Wang X; Ren J; Wei J; Dong K; Zhang H
Cancer Gene Ther; 2012 Apr; 19(4):271-81. PubMed ID: 22281755
[TBL] [Abstract][Full Text] [Related]
8. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs.
Jin W; Liu Y; Xu SG; Yin WJ; Li JJ; Yang JM; Shao ZM
Breast Cancer Res Treat; 2010 Nov; 124(1):39-48. PubMed ID: 20037778
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
[TBL] [Abstract][Full Text] [Related]
12. Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis.
Zhou L; Zhao X; Han Y; Lu Y; Shang Y; Liu C; Li T; Jin Z; Fan D; Wu K
FASEB J; 2013 Dec; 27(12):4929-39. PubMed ID: 23982143
[TBL] [Abstract][Full Text] [Related]
13. Exogenous expression of UHRF1 promotes proliferation and metastasis of breast cancer cells.
Li XL; Xu JH; Nie JH; Fan SJ
Oncol Rep; 2012 Jul; 28(1):375-83. PubMed ID: 22552622
[TBL] [Abstract][Full Text] [Related]
14. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
15. UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4.
He H; Lee C; Kim JK
Cell Death Dis; 2018 Feb; 9(2):164. PubMed ID: 29415984
[TBL] [Abstract][Full Text] [Related]
16. Functional dissection of the role of UHRF1 in the regulation of retinoblastoma methylome.
Kan G; He H; Zhao Q; Li X; Li M; Yang H; Kim JK
Oncotarget; 2017 Jun; 8(24):39497-39511. PubMed ID: 28467809
[TBL] [Abstract][Full Text] [Related]
17. UHRF1 expression is upregulated and associated with cellular proliferation in colorectal cancer.
Kofunato Y; Kumamoto K; Saitou K; Hayase S; Okayama H; Miyamoto K; Sato Y; Katakura K; Nakamura I; Ohki S; Koyama Y; Unoki M; Takenoshita S
Oncol Rep; 2012 Dec; 28(6):1997-2002. PubMed ID: 23023523
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of ICBP90 contributes to doxorubicin resistance.
Wang J; Song Y; Xu S; Zhang Q; Li Y; Tang D; Jin S
Eur J Pharmacol; 2011 Apr; 656(1-3):33-8. PubMed ID: 21296067
[TBL] [Abstract][Full Text] [Related]
19. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
20. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
